MAPK3 and breast carcinoma: Relevant studies have shown that BCSCs can activate the STAT3 signaling pathway or the Notch-1-PTEN-ERK1/2 signaling pathway under the stimulation of certain transcription factors and inflammatory factors to promote breast cancer recurrence (137, 138).